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The object of this study was to determine the effect of Cinnamomum zeylanicum (cinnamon) on glycemic/lipid balance, 
resistin and ghrelin. 84 obese Type 2 diabetic patients were assigned in 2 groups which consumed 8 g and 4 g of cinnamon 
powder. Anthropometric, hormonal and biochemical parameters were measured before and after 10 weeks of treatment. We 
found that cinnamon decrease BMI and waist circumference respectively of -5.52±1.47 kg/m² and -10.72±6.12 cm for group 
2 of and a decrease of -4.45±1.46 kg/m² and -6.86±5.5 cm in group 1. Our results also showed a decrease of the glucose 
level of -1,173±0, 75 mmol/L in group 2 and -0, 8932±0, 72 mmol/L in group 1 and a decrease of insulin levels  
of -3.24±2.85 μUI/L in group 2 and -2.54±2.8 μUI/L in group 1. The assays showed that resistin secretion decreased  
by -2.08±1.09 ng/mL for the 8 g dose and -1.59±0.926 ng/mL for the 4 g dose, and there was an increase in ghrelin secretion 
of +1.55±2.21 μg/mL for the 8 g dose and + 2.49±1.13 μg/mL for the 4 g dose. 
The results confirmed the anti-hyperglycemic and hypolipidemic effects of cinnamon opening a new approach to 
studying how the compounds derived from certain spices regulate the endogenous release of hormones such as ghrelin and 
resistin for therapeutic intervention. 
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Obesity is a serious public health problem of the 21st 
century on account of the increased associated risk of 
hypertension, coronary heart disease, Type 2 diabetes, 
stroke, certain types of cancer, osteoarthritis, sleep 
apnea and other disorders such as infertility1. 
Despite the global voluntary goal of curbing rising 
obesity by 20252,3, overweight and obesity was 
increased in almost all countries. In 2014, more than 
one in three adults over the age of 18 was overweight 
and more than one in ten was obese2. 
Tunisia is affected by this public health problem 
and is at an advanced stage. Moreover, the obesity 
prevalence had more than doubled in the last two 
decades in our country4. It was a complex and 
multifactorial disease with overeating, physical 
inactivity and genetic susceptibility as the primary 
causal factors. 
On the other hand, being obese or overweight is 
strongly related to diabetes. Adiposity was the most 
critical risk factor for diabetes. In addition, diabetes, 
whose complications (blindness, amputations, kidney 
failure) were expensive, can represent a weighty 
burden in the long term for health budgets5. 
The usual recommendations were aimed at improving 
lifestyles such as switching to a healthier diet, increasing 
physical activity and medication compliance. However, 
there were problems faced with the difficulty of lifestyle 
change and its long-term maintenance and side effects 
associated with the medication. 
Herbal medicine can represent an alternative or a 
valuable addition to the conventional prescription of 
drugs. In this context, several experimental studies 
had described the effects of Cinnamomum zeylanicum 
(cinnamon) on various biological parameters such as 
blood glucose, lipid profile, adiposity and 
inflammatory markers. 
———— 
*Corresponding author 
SFAR et al.: CINNAMONREDUCESDIABETESINOBESEDIABETICMEN 
 
 
695
In addition to its antioxidant, anti-microbial, anti-
cancer and its effects enhancing the components of 
cardiovascular disease, cinnamon had also been 
known to have effects against neurological diseases, 
such as Parkinson's and Alzheimer's. It contained 
mainly essential oils and other by-products, such as 
cinnamaldehyde, cinnamic acid and cinnamate6. 
In this work, we proposed to study the interest of 
the use of cinnamon on blood glucose, lipids, resistin 
and ghrelin in a population of obese and diabetic men. 
 
Materials and methods 
Study participants 
This work was a prospective analytical study 
carried out on male patients followed during the 
consultation by the specialist doctor of the ‘C’ service 
of Diabetology and metabolic diseases at the National 
Institute of Nutrition of Tunis, Tunisia. 
In this study, 84 male patients were selected to 
participate in using the exclusion and inclusion 
criteria. The criteria of exclusion were: Type 1 
diabetics, the diabetes age >5 years, patients treated 
with insulin, diabetics with dental problems and 
chewing difficulties, associated disease states such as 
renal, cardiac and hepatic insufficiency, taking of any 
prescribed medication, restricted diets and any 
allergic antecedents to cinnamon products. 
Patients were selected for enrollment met the 
following criteria: male, obese patients with Type 2 
diabetes, the age of diabetes=<5 years, 30 years old 
and over, under oral antidiabetic (OAD) treatment, 
with unbalanced glycemic counts during previous 
consultations and following a diet. 
All the procedures followed were in accordance 
with the ethical standards of the committee 
responsible for human experimentation of the 
National Institute of Nutrition and Food Technology 
of Tunis, Tunisia and the Helsinki Declaration of 
1975 revised in 2008. Eligible patients gave written 
informed consent to participate in the study. 
 
Study Design 
All participants were interviewed and informed 
about the principles of the study during the 
consultation. Patients were divided into two groups of 
34 and 50 subjects. Patients in the first group (N=34) 
received a dose of 4 g of cinnamon powder daily for 
10 weeks. Patients in the second group (N=50) 
received a dose of 8 g of cinnamon powder daily for 
10 weeks. Cinnamon powder doses weighed using an 
electronic balance. Food and the quantities placed 
hygienically in bags to be distributed to patients. We 
recommended that patients regularly take a cinnamon 
powder at breakfast with a sugar-free yogurt or with a 
glass of milk for the group with a dose of 4 g/day and 
take a second time at night for the group having a 
dose 8 g/day. We provided for each subject of the  
2 groups the number of bags needed for a week. Each 
patient returns at the end of the week to recover the 
bags of the following week and this schedule was 
adhered to throughout the investigation until the end 
of the 10th week. The patients were seen by the 
dietician each time to check if there is a difficulty in 
applying the protocol to which he voluntarily adhered. 
 
Biochemical Analysis 
The assays were carried out in collaboration with 
the Laboratory of Biochemistry and Biotechnology at 
the Faculty of Sciences of Tunis. A 5 mL blood 
sample was collected from each patient in the 
morning after 12 h fasting. Fasting lipid profile 
including total cholesterol (TC), triacylglycerol (TG), 
high-density lipoprotein cholesterol (HDL-C) and 
fasting blood glucose (FBG) was determined for each 
patient at baseline using the standard enzymatic 
method, Beckman kit on Beckman DXC  
600 analyzer. The HbA1c assay was performed by 
HPLC (High-Pressure Liquid Chromatography) ion 
exchange on the Tosoh G8 analyzer. Measurement of 
the resistin was determined by the ELISA method 
"Millipore#EZHR-95K with a sensitivity ranging 
from 0.16 ng/mL to 10 ng/mL". Insulin was assayed 
by IRMA (Immunoradiometric Assay). The 
"HOMAR-IR" (Homeostatic model assessment of 
insulin resistance) was calculating. Measurement of 
ghrelin was carried out with the RIA technique 
(radioimmunoassay) by competition using commercial 
kits for research by the lab Linco (LINCO Research, 
Inc., Missouri, United States) kit: GHRA-88 HK for 
ghrelin active with a sensitivity of 7.8 pg/mL. 
 
Anthropometric and Physical Measurements 
The body weight (kg), the size (m), the Body Mass 
Index (BMI) defined by the ratio in kg of height in 
meters squared, waist circumference (WC), systolic 
(SAP) and diastolic (DAP) arterial pressures 
measured. A digital electronic balance measured the 
body weight; height was measured with a graduated 
measuring rod in centimeters. All anthropometric, 
dietary intakes, blood sampling and biochemical 
measurements were re-evaluated at the end of the 
intervention period in both groups. 
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Statistical analyses 
The data was entered on Excel 2007 and analyzed 
using SPSS software in version 13.0. We used 
Student's statistical test for paired series. The 
significance level is p<0.05. 
 
Results and discussion 
The purpose of this investigation was to evaluate 
the interest of cinnamon, taken at two different doses 
on anthropometric, hormonal and lipid parameters in 
two groups of obese and diabetic men. 
We had searched for the different correlations 
between the various parameters studied before and 
after the treatment and the different variations of these 
parameters observed after taking a dose of 8 g of 
cinnamon and a dose of 4 g of cinnamon for  
10 weeks. 
The population sample consisted of a group 1 of 34 
men who followed a diet and received a dose of 4 g of 
cinnamon and a group 2 of 50 men who received a 
dose of 8 g obese and diabetic whose average age is 
48±4 years old. It consists of evaluating lipid 
parameters, blood glucose, insulin, resist in and 
ghrelin in two groups of obese and diabetic men 
before and after taking cinnamon according to a well-
defined protocol. 
 
Effect of Cinnamon on Anthropometric Parameters 
We compared the anthropometric parameters 
before and after the management of this population. 
We found a good evolution of the different measures. 
Indeed, there was a decrease in BMI (Fig. 1 & Fig. 2), 
waist circumference respectively of 
-5.52±1.47 kg/m² and -10.72±6.12 cm for subjects 
who received a dose of 8 g of cinnamon and a 
decrease of -4.45±1.46 kg/m² and -6.86±5.5 cm in 
subjects who received a 4 g dose of cinnamon 
(Table1). A study by Akilen et al. in a group of  
58 patients with Type 2 diabetes (33 females and 25 
males) aged 54.9±9.8 years treated with oral 
antidiabetic only and who received a dose of 2 g of 
cinnamon per day for 12 weeks showed a significant 
diminution in BMI, weight and waist circumference 
(p<0.05). They also highlighted the improvement in 
systolic and diastolic blood pressure7 in accordance 
with our results in which these values were reduced 
by -1.9±1.5 mmHg for PAS and -4.79±231 mmHg for 
PAD at the dose of 4g and -24.16±1.87 mmHg for 
PAS and -7.59±358 mmHg for PAD at the dose of  
8 g. This effect on blood pressure was also 
demonstrated by the study of Ziegenfuss et al. 
conducted on 22 people consuming 500 mg per day of 
a cinnamon extract for 12 weeks8 as well as the results 
of Preuss work. HG et al. on hypertensive rats in a 
series of three experiments, received different 
amounts of cinnamon, the results showed a dose-
dependent effect on the regulation of diastolic and 
systolic blood pressure9. However, there were other 
studies which did not report a significant decrease in 
BMI, weight or waist circumference compared with a 
placebo in a control group like Wickenberg J et al.10 
and Vafa et al.11. The latter showed that after 
consuming 3 g/ day of cinnamon for 8 weeks, there 
was no significant difference between the group 
treated with cinnamon and the group received placebo 
for anthropometric variables. There were also no 
changes in systolic and diastolic blood pressure after 
the intervention compared to the baseline in this 
study11. These differences could be due, among other 
things, to the limits of studies regarding duration or 
dose as well as the ethnic and physiological 
 
 
Fig. 1 — Variation in BMI before and after taking 8 g of cinnamon 
 
 
 
Fig. 2 — Variation in BMI before and after taking 4 g of cinnamon 
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particularities of the populations studied. According 
to the Preuss HG et al. research on animals, the 
mechanism by which cinnamon acts on blood 
pressure was explained by peripheral vasodilatation9. 
Mollazadeh et al. demonstrated that this vasodilation 
might be partially due to Ca2+channel blockage. 
Indeed, the normalization of the vascular contractility 
by the restoration of the normal influx of Ca2+in 
parallel with its insulinotropic effect were the main 
mechanisms of prevention of the development of 
hypertension in patients with insulin deficiency and 
insulin resistance12,13. 
 
Effect of cinnamon on blood glucose and insulin 
On the glycemic balance, our results showed a decrease 
of the mean glucose level of -1,173±0,75 mmol/L in the 
group that received 8 g of cinnamon (Fig. 3) and  
-0,8932±0,72 mmol/L in the group that benefited 4 g 
of cinnamon (Fig. 4) as showed in Table 2. A 
decrease in mean insulin levels of -3.24±2.85 μUI/L 
in group 2 and -2.54±2.8 μUI/L in group 1 (Table 3 
and Fig. 5). HbA1c decreased by (-1.1254±0.18) % 
after taking 8 g of cinnamon while it remained high 
after taking 4 g of cinnamon (Table 2). This 
difference could be explained by insufficient 
adaptation time or an ineffective dose in the first 
group. The decreased in insulin and blood glucose 
indicated the decline in the average of the HOMA-IR 
of -1.75±1.43 after taking 8 g of cinnamon as showed 
in Table 3. Several studies noted the role of cinnamon 
in regulating the glycemic balance, which was quoted 
by Khan et al. who had demonstrated, after 40 days, 
in a group of 60 individuals (30 women and 30 men) 
diabetics aged 52.2±6.32 years, that the addition of 1, 
3 or 6 g of cinnamon per day to the diet showed a 
significant decrease in blood glucose. Values were 
significantly lower only in the group receiving 6 g 
cinnamon (p<0.05) after 20 days14. 
Similarly, in our study, the result was less important 
in the group receiving 4 g of cinnamon. The effect of 
cinnamon on blood sugar is dose-dependent. The study 
of Suksomboon, et al. also confirmed the effect of 
Table 1 — Anthropometric parameters in both groups before and after taking cinnamon 
Parameters Group N Means before  
10 weeks of 
cinnamon intake 
Means after  
10 weeks of 
cinnamon intake 
Mean  
deviation 
p 
Age (year) OAD + 8 g of Cinnamon per day 50 48,16±4,36 _ _ _ 
 OAD + 4 g of Cinnamon per day 34 48,47±4,48 _ _ _ 
BMI (kg/m2) OAD + 8 g of Cinnamon per day 50 35,31±4,58 29 ,79±3,75 5,52±1,47 0,00 
 OAD + 4 g of Cinnamon per day 34 35,11±4,37 30,85±3,76 4,25±1,46 0,00 
WC (cm) OAD + 8 g of Cinnamon per day 50 105,36±9,37 94,64±8,20 10,72±6,12 0,00 
 OAD + 4 g of Cinnamon per day 34 106,53±9,33 99,66±8,36 6,86±5,51 0,00 
SBP (mmHg) OAD + 8 g of Cinnamon per day 50 142,10±11,02 117,94±8,20 24,16±1,87 0,00 
 OAD + 4 g of Cinnamon per day 34 141,18±10,80 121,28±9,28 1,99±1,52 0,00 
DBP (mmHg) OAD + 8 g of Cinnamon per day 50 89,32±4,20 81,73±3,84 7,59±0,35 0,00 
OAD + 4 g of Cinnamon per day 34 88,91±4,28 84,12±4,05 4 ,79±0,23 0,00 
 
 
Fig. 3 — Variation in blood glucose before and after taking 8 g of 
cinnamon 
 
 
 
Fig. 4 — Variation in blood glucose before and after taking 4 g of 
cinnamon 
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cinnamon on the regulation of glycemia15,16. Magistrelli 
et al. Suggested that cinnamon could be efficient in 
moderating postprandial glucose levels inobese and 
normal adults17. Recently, Anderson RA et al. in a study 
of 137 diabetic subjects who received a commercial 
preparation of cinnamon (500 mg/day) or placebo for  
2 months, showed a significant decrease in fasting and 
postprandial glucose. Insulin sensitivity, assessed by 
HOMA-IR, was also significantly enhanced by 
cinnamon extract18. Crowford et al. did a study of  
109 age-matched Type 2 diabetics at a military base in 
the United States. He founded that cinnamon reduced 
HbA1C by 0.83% compared to the usual care alone that 
lowers HbA1C 0.37%19. An efficient blood glucose 
control was the key to preventing the complications of 
diabetes and improve quality of life in diabetic patients.  
A sustained reduction of hyperglycemia decreased the 
risk of developing microvascular complications. 
However, Blevins et al. reported that cinnamon 
administration had no significant effect on blood 
glucose, lipid and HbA1c levels in people with Type 2 
diabetes20. These results did not agree with what was 
found. The difference could be assigned to the fact that 
the dose studied is not the same, which could affirm that 
the cinnamon effect on these parameters is dose-
dependent. The hypoglycemic activity of cinnamon was 
since it prevented the insulin resistance development, in 
part by improving insulin signaling possibly via the NO 
pathway in skeletal muscle21. In another study, the 
reduction in blood sugar with cinnamon was explained 
by various mechanisms like  reducing intestinal 
absorption of glucose, stimulation of cellular uptake of 
glucose, glycogen synthesis, the release of insulin, 
potentiation of insulin receptor activity and inhibition of 
gluconeogenesis6. Still, cinnamon bark extracts were 
demonstrated potentially useful for controlling the 
Table 2 — Serum glucose, HbA1c, TG, total cholesterol, Triglyceride, HDL-C concentrations in both groups before and  
after 10 weeks of cinnamon intake 
Parameters Group N Means before 10 weeks 
of cinnamon intake 
Means after 10 weeks 
of cinnamon intake 
Mean deviation p 
FBG (mg/dL) OAD + 8 g of Cinnamon per day 50 7,51±1,29 6,34±0,97 1,17±0,75 0,00 
 OAD + 4 g of Cinnamon per day 34 7,40±1,35 6,50±1,08 0,89±0,71 0,00 
HbA1c 
(mmol/mol) 
OAD + 8 g of Cinnamon per day 50 9,37±1,54 8,25±1,35 1,12±0,18 0,00 
 OAD + 4 g of Cinnamon per day 34 9,92±1,51 1,08±1,47 0,05±1,28 0,794 
CT 
(mmol/l) 
OAD + 8 g of Cinnamon per day 50 5,31±1,06 4,67±0,94 0,63±0,12 0,00 
 OAD + 4 g of Cinnamon per day 34 5,53±1,12 5,04±1,02 0,49±0,10 0,00 
TG 
(mmol/l) 
OAD + 8 g of Cinnamon per day 50 1,82±0,22 0,94±0,19 0,20±0,02 0,00 
 OAD + 4 g of Cinnamon per day 34 1,80±0,02 1,66±0,21 0,14±0,01 0,00 
HDL-C 
(mmol/l) 
OAD + 8 g of Cinnamon per day 50 0,75±0,18 0,94±0,23 0,18±0,18 0,00 
OAD + 4 g of Cinnamon per day 34 0,72±0,14 0,94±0,21 0,21±0,20 0,00 
 
Table 3 — Insulin, resistin, ghrelin and HOMA-IR concentration in both groups before and after taking cinnamon 
Parameters Group N Means before 10 weeks  
of cinnamon intake 
Means after 10 weeks of 
cinnamon intake 
Mean 
deviation 
p 
Insulin 
μUI/L 
OAD +8 g of Cinnamon per day 50 14,47±4,55 11,23±3,23 3,24±2,85 0,00 
 OAD +4 g of Cinnamon per day 34 14,45±4,89 11,90±3,80 2,54±2,80 0,00 
Resistinpg/mL 
 
OAD +8 g of Cinnamon per day 50 10,60±3,21 2,08±1,09 2,08±1,09 0,00 
 OAD +4 g of Cinnamon per day 34 10,09±3,16 8,50±2,63 1,59±0,92 0,00 
Ghrelin 
pg/mL 
OAD +8 g of Cinnamon per day 50 20,42±5,24 21,97±6,53 -1,55±2,21 0,00 
 OAD +4 g of Cinnamon per day 34 19,59±5,20 22,09±6,16 -2,49±1,13 0,00 
HOMA-IR 
 
OAD +8 g of Cinnamon per day 50 4,99±2,24 3,23±1,31 1,75±1,43 0,00 
OAD +4 g of Cinnamon per day 34 4,94±2,43 3,43±1.51 1,51±1,4 0,00 
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absorption of glucose in people with diabetes by 
inhibiting intestinal a-glucosidase and pancreatic  
alpha-amylase22.  
 
Effect of Cinnamon on Lipid Profile 
Regarding the lipid profile (Table 2), our study 
showed a significant decrease after administration of 
cinnamon total cholesterol and triglyceride levels, 
each with a difference of -0.6378±0.12 mmol/L 
(p=0,000) and -0, 2006±0.02 mmol/L (p=0,000) for 
the dose of 8 g and a difference of -0.493±0.100 
mmol/L (p=0,000) and -0.1424±,018 mmol/L 
(p=0,000) for the dose of 4 g. On the other hand,  
there was an increase in HDL-cholesterol of 
0.189±0.182 mmol/L for the intake of 8 g and 
0.2150±0.205 mmol/L (p=0,000) for taking a dose of 
4 g. Cholesterol-lowering and lipid effects of 
cinnamon showed in numerous studies. Kim et al. 
also reported that levels of triglycerides and total 
cholesterol decreased, and the level of HDL 
cholesterol increased in dB/dB mice treated with 
cinnamon23. The study by Badalzadeh et al. showed 
that 200 mg/kg of cinnamon per day significantly 
reduced serum levels of total cholesterol, LDL-
cholesterol and raised HDL-cholesterol and HDL-
C/LDL-C levels compared to the control group for 8 
weeks24. The study by Khan et al.15 also showed a 
diminution in triglyceride, total cholesterol and LDL-
cholesterol levels in humans. Shatwan IA et al. found 
that HDL-cholesterol increased significantly, while 
cholesterol, LDL-cholesterol and triglycerides 
decreased in streptozotocin-induced diabetic rats and 
fed 5% cinnamon for 8 weeks25. Cinnamon had strong 
inhibiting activity against the oxidation of LDL-C 
mediated by copper, phagocytosis LDL-C by 
macrophages and possesses potent inhibitory activity 
transfer protein of cholesteryl ester (CETP)26. Actual 
evidence overwhelming confirmed the role of LDL-C 
in the atherosclerosis pathogenesis and the risk of 
cardiovascular disease (CVD). The decreased in  
LDL-C was associated with a reduced risk of CVD27. 
 
Effect of Cinnamon on the Hormones of Satiety Ghrelin and 
Resistin 
The assays showed (Table 3) that resistin secretion 
decreased by -2.08±1.09 ng/mL for the 8 g dose  
(Fig. 6) and -1.59±0.926 ng/mL for the 4 g dose,  
there was an increase in ghrelin secretion of 
+1.55±2.21 μg/mL for the 8 g dose (Fig. 7) and 
+2.49±1.13 μg/mL for the 4 g dose (Fig. 8). It was 
known that adiponectin, leptin and resistin are  
3 adipokines, which played a major role in the 
regulation of insulin sensitivity. While adiponectin 
was an anti-inflammatory mediator, leptin and resistin 
exert pro-inflammatory activity. The studies of 
Baranova et al. demonstrated that adiponectin levels 
were decreased in obese patients with insulin 
resistance given elevated plasma concentrations of 
resistin28. These high concentrations of leptin  
and resistin in obese subjects were at the origin of 
various complications, including cardiovascular 
complications. In our study, we found that after 
treatment, there was a drop in its plasma levels of 
resistin. This decrease would result from the drop of 
the fat mass, besides, IMC and resistin had negative 
correlations (r=0.444, p=0.001). As for ghrelin, our 
 
 
Fig. 5 — Variation in insulin levels before and after taking 4 g 
of cinnamon 
 
 
Fig. 6 — Variation in resistin level before and after taking 8 g of 
cinnamon 
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results showed a rise in its rates. It was correlated 
negatively with BMI (p=-0.489, r=0.000). 
Ghrelin is a leptin antagonist hormone, they had 
negative correlations between them, as demonstrated 
by the study of Scerif et al.29. As a result, increased 
plasma ghrelin levels in our patients showed a decline 
in leptin levels, reducing the inflammatory and 
cardiovascular risks that arise from hyperleptinemia 
in obese subjects. Studies on the effect of cinnamon 
on resistin and ghrelin were few. By studying the 
impact of DLBS3233, a combination of standardized 
extracts containing Lagerstroemia speciosa and 
Cinnamomumburmannii on glucose uptake, insulin 
signaling and adiponectin secretion, Mayasari et al. 
showed that DLBS3233 up-regulated adiponectin and 
down-regulated resistin. The mechanism of action of 
DLBS3233 was via PPARγ, increasing insulin 
sensitivity and decreasing insulin resistance30. 
However, the team of Joanna Hlebowicz, et al. 
conducted studies on 15 healthy individuals  
(9 men and 6 women) in order to explore the effect of 
1 g and 3 g cinnamon per day, results suggested a 
lower but negligible ghrelin, this difference may be 
due to the reduced number of subjects treated31. 
Another study demonstrated that cinnamaldehyde as a 
transient receptor potential ankyrin 1 (TRPA1) 
agonist in mouse stomach epithelial cells reduced the 
secretion of ghrelin in vitro32. The same results were 
found by Camacho et al.33. Thus, in other studies, the 
rate of ghrelin decreased with cinnamon intake, 
contrary to the results obtained in our study. 
There was an improvement in the different 
parameters after having cinnamon except for  
HDL-cholesterol and ghrelin. Taking cinnamon 
promoted a better glycemic and lipid profile by 
improving insulin sensitivity and increasing the level 
of HDL-cholesterol. Ghrelin and resistin levels 
decreased, lowering the adverse effects of this latter 
on insulin sensitivity and its pro-inflammatory roles. 
The results confirmed the anti-hyperglycemic and 
hypolipidemic effects of cinnamon opening a new 
approach to studying how the compounds derived 
from certain spices regulate the endogenous release of 
hormones such as ghrelin and resistin for therapeutic 
intervention. However, it should be noted that these 
studies examined the immediate effect of cinnamon 
on hormones, while our target the long-term effect. 
Also, there were differences in the population studied 
and the methods and protocols used. Let's add that 
different species of cinnamon do not all have the  
same effect. 
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